Diego Caprioglio, Daiana Mattoteia, Federica Pollastro, Roberto Negri, Annalisa Lopatriello, Giuseppina Chianese, Alberto Minassi, Juan A Collado, Eduardo Munoz, Orazio Taglialatela-Scafati, Giovanni Appendino
Journal: Journal of natural products 2021;83(5):1711-1715
PMID: 32315173
Spurred by a growing interest in cannabidiolquinone (CBDQ, HU-313, ) as a degradation marker and alledged hepatotoxic metabolite of cannabidiol (CBD, ), we performed a systematic study on the oxidation of CBD () to CBDQ () under a variety of experimental conditions (base-catalyzed aerobic oxidation, oxidation with metals, oxidation with hypervalent iodine reagents). The best results in terms of reproducibility and scalability were obtained with λ-periodinanes (Dess-Martin periodinane, 1-hydroxy-1λ,2-benziodoxole-1,3-dione (IBX), and SIBX, a stabilized, nonexplosive version of IBX). With these reagents, the oxidative dimerization that plagues the reaction under basic aerobic conditions was completely suppressed. A different reaction course was observed with the copper(II) chloride-hydroxylamine complex (Takehira reagent), which afforded a mixture of the hydroxyiminodienone and the halogenated resorcinol . The λ-periodinane oxidation was general for phytocannabinoids, turning cannabigerol (CBG, ), cannabichromene (CBC, ), and cannabinol (CBN, ) into their corresponding hydroxyquinones (, , and , respectively). All cannabinoquinoids modulated to a various extent peroxisome proliferator-activated receptor gamma (PPAR-γ) activity, outperforming their parent resorcinols in terms of potency, but the iminoquinone , the quinone dimers and , and the haloresorcinol were inactive, suggesting a specific role for the monomeric hydroxyquinone moiety in the interaction with PPAR-γ.
Full Text Sources:
Other Literature Sources:
Miscellaneous:
Research Materials:
Chemical Information:
Full Text Sources:
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.